• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Polo样激酶1通过使p53去磷酸化并诱导p53降解来调节紫外线照射后的有丝分裂停滞。

Polo-like kinase 1 regulates mitotic arrest after UV irradiation through dephosphorylation of p53 and inducing p53 degradation.

作者信息

Chen Jie, Dai Gu, Wang Yi-Qian, Wang Sheng, Pan Fei-Yan, Xue Bin, Zhao Dong-Hong, Li Chao-Jun

机构信息

Jiangsu Key Laboratory for Molecular and Medical Biotechnology, Life Sciences College, Nanjing Normal University, Nanjing 210097, China.

出版信息

FEBS Lett. 2006 Jun 26;580(15):3624-30. doi: 10.1016/j.febslet.2006.05.047. Epub 2006 May 30.

DOI:10.1016/j.febslet.2006.05.047
PMID:16753148
Abstract

Ultraviolet (UV) irradiation can result in cell cycle arrest. The reactivation of Polo-like kinase 1 (Plk1) is necessary for cell cycle reentry. But the mechanism of how Plk1 regulates p53 in UV-induced mitotic arrest cells remained elusive. Here we find that UV treatment leads HEK293 cells to inverse changes of Plk1 and p53. Over-expression of Plk1 rescue UV-induced mitotic arrest cells by inhibiting p53 activation. Plk1 could also inhibit p53 phosphorylation at Ser15, thus facilitates its nuclear export and degradation. Further examination shows that Plk1, p53 and Cdc25C can form a large complex. Plk1 could bind to the sequence-specific DNA-binding domain of p53 and active Cdc25C by hyperphosphorylation. These results hypothesize that Plk1 and Cdc25C participate in recovery the mitotic arrest through binding to the different domain of p53. Cdc25C may first be actived by Plk1, and then its phosphatase activity makes p53 dephosphorylated at Ser15.

摘要

紫外线(UV)照射可导致细胞周期停滞。Polo样激酶1(Plk1)的重新激活是细胞周期重新进入所必需的。但在紫外线诱导的有丝分裂停滞细胞中,Plk1如何调节p53的机制仍不清楚。在此,我们发现紫外线处理导致HEK293细胞中Plk1和p53发生相反变化。Plk1的过表达通过抑制p53激活来挽救紫外线诱导的有丝分裂停滞细胞。Plk1还可抑制p53在Ser15位点的磷酸化,从而促进其核输出和降解。进一步研究表明,Plk1、p53和Cdc25C可形成一个大复合物。Plk1可与p53的序列特异性DNA结合结构域结合,并通过过度磷酸化激活Cdc25C。这些结果推测,Plk1和Cdc25C通过与p53的不同结构域结合参与有丝分裂停滞的恢复。Cdc25C可能首先被Plk1激活,然后其磷酸酶活性使p53在Ser15位点去磷酸化。

相似文献

1
Polo-like kinase 1 regulates mitotic arrest after UV irradiation through dephosphorylation of p53 and inducing p53 degradation.Polo样激酶1通过使p53去磷酸化并诱导p53降解来调节紫外线照射后的有丝分裂停滞。
FEBS Lett. 2006 Jun 26;580(15):3624-30. doi: 10.1016/j.febslet.2006.05.047. Epub 2006 May 30.
2
Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.p21(Waf1) 对 Polo 样激酶 1 (PLK1) 的抑制作用介导了 p53 依赖性的 caspase 非依赖性有丝分裂死亡的预防。
Cell Signal. 2011 Nov;23(11):1816-23. doi: 10.1016/j.cellsig.2011.06.016. Epub 2011 Jun 29.
3
Plk1-mediated mitotic phosphorylation of PinX1 regulates its stability.Plk1 介导的 PinX1 的有丝分裂磷酸化调节其稳定性。
Eur J Cell Biol. 2010 Oct;89(10):748-56. doi: 10.1016/j.ejcb.2010.05.005. Epub 2010 Jun 22.
4
Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.有丝分裂期DNA损伤处理后Polo样激酶1的失活与共济失调毛细血管扩张症突变激酶无关。
Mol Cancer Res. 2004 Jul;2(7):417-26.
5
Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation.金雀异黄素诱导的神经元凋亡和G2/M期细胞周期阻滞与MDC1上调和PLK1下调有关。
Eur J Pharmacol. 2007 Dec 1;575(1-3):12-20. doi: 10.1016/j.ejphar.2007.07.039. Epub 2007 Jul 28.
6
Promotion of mitosis by activated protein kinase B after DNA damage involves polo-like kinase 1 and checkpoint protein CHFR.DNA损伤后,活化的蛋白激酶B对有丝分裂的促进作用涉及polo样激酶1和检查点蛋白CHFR。
Mol Cancer Res. 2003 Nov;1(13):959-69.
7
Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.转移性肝细胞癌中异常的Polo样激酶1-Cdc25A信号通路
Clin Cancer Res. 2008 Nov 1;14(21):6813-20. doi: 10.1158/1078-0432.CCR-08-0626.
8
Purification and proteomic identification of putative upstream regulators of polo-like kinase-1 from mitotic cell extracts.有丝分裂细胞抽提物中 polo 样激酶-1 上游假定调控因子的纯化和蛋白质组学鉴定。
FEBS Lett. 2010 Oct 22;584(20):4299-305. doi: 10.1016/j.febslet.2010.09.025. Epub 2010 Sep 25.
9
Small interfering RNA-mediated Polo-like kinase 1 depletion preferentially reduces the survival of p53-defective, oncogenic transformed cells and inhibits tumor growth in animals.小干扰RNA介导的Polo样激酶1缺失优先降低p53缺陷的致癌转化细胞的存活率,并抑制动物肿瘤生长。
Cancer Res. 2005 Apr 1;65(7):2698-704. doi: 10.1158/0008-5472.CAN-04-2131.
10
Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization.polo样激酶1底物识别的分子与结构基础:对中心体定位的影响
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3107-12. doi: 10.1073/pnas.0609131104. Epub 2007 Feb 16.

引用本文的文献

1
Polo-like kinases and UV-induced skin carcinogenesis: What we know and what's next.波罗样激酶与紫外线诱导的皮肤癌发生:我们所知与后续研究方向
Photochem Photobiol. 2025 Jul 9. doi: 10.1111/php.70002.
2
KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway.KIF22 通过调控 CDC25C/CDK1/细胞周期蛋白 B1 通路促进多发性骨髓瘤的进展。
J Cancer Res Clin Oncol. 2024 May 7;150(5):239. doi: 10.1007/s00432-024-05747-w.
3
DNA damage checkpoint execution and the rules of its disengagement.DNA损伤检查点的执行及其解除的规则。
Front Cell Dev Biol. 2022 Oct 6;10:1020643. doi: 10.3389/fcell.2022.1020643. eCollection 2022.
4
The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review.CDC25C在细胞周期调控及临床癌症治疗中的作用:一项系统综述
Cancer Cell Int. 2020 Jun 3;20:213. doi: 10.1186/s12935-020-01304-w. eCollection 2020.
5
p53 modifications: exquisite decorations of the powerful guardian.p53 修饰:强大守护者的精致装饰。
J Mol Cell Biol. 2019 Jul 19;11(7):564-577. doi: 10.1093/jmcb/mjz060.
6
The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?有丝分裂癌症靶点 Polo 样激酶 1:癌基因还是肿瘤抑制因子?
Genes (Basel). 2019 Mar 11;10(3):208. doi: 10.3390/genes10030208.
7
Preclinical Childhood Sarcoma Models: Drug Efficacy Biomarker Identification and Validation.临床前儿童肉瘤模型:药物疗效生物标志物的鉴定与验证
Front Oncol. 2015 Aug 26;5:193. doi: 10.3389/fonc.2015.00193. eCollection 2015.
8
Polo-like kinase-1 in DNA damage response.DNA损伤反应中的Polo样激酶-1
BMB Rep. 2014 May;47(5):249-55. doi: 10.5483/bmbrep.2014.47.5.061.
9
Battle of the eternal rivals: restoring functional p53 and inhibiting Polo-like kinase 1 as cancer therapy.永恒对手之间的较量:恢复功能性p53并抑制Polo样激酶1作为癌症治疗方法
Oncotarget. 2013 Jul;4(7):958-71. doi: 10.18632/oncotarget.1096.
10
Mitotic Kinases and p53 Signaling.有丝分裂激酶与p53信号传导
Biochem Res Int. 2012;2012:195903. doi: 10.1155/2012/195903. Epub 2012 Jul 19.